WASHINGTON (dpa-AFX) - Regeneron Pharmaceuticals (REGN) reported a profit for first quarter that decreased from last year.
The company said its profit declined to $293 million, or $2.57 per share. This was down from $336 million, or $2.88 per share, in last year's first quarter.
Analysts had expected the company to earn $2.58 per share, according figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company said revenue for the quarter rose 37.9% to $1.20 billion. This was up from $0.87 billion last year.
Regeneron Pharmaceuticals earnings at a glance:
-Earnings (Q1): $293 Mln. vs. $336 Mln. last year. -Earnings Decline (Y-o-Y): -12.8% -EPS (Q1): $2.57 vs. $2.88 last year. -EPS Decline (Y-o-Y): -10.8% -Analysts Estimate: $2.58 -Revenue (Q1): $1.20 Bln vs. $0.87 Bln last year. -Revenue Change (Y-o-Y): 37.9%
Copyright RTT News/dpa-AFX